FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Prothena Scraps Birtamimab After Phase 3 Miss

[ Price : $8.95]

Prothena discontinues the development of birtamimab, its investigational treatment for AL amyloidosis, after the drug failed to me...

Covid Vaccine Nixed for Children/Pregnant Women

[ Price : $8.95]

HHS removes Covid-19 vaccine recommendations for healthy children and healthy pregnant women from CDCs recommended immunization sc...

Gene Therapy Trial on Hold After Death

[ Price : $8.95]

FDA places a clinical hold on a Rocket Pharmaceuticals Phase 2 pivotal trial for RP-A501, an investigational gene therapy for Dano...

FDA Clears Olympus Endoscope Series

[ Price : $8.95]

FDA gives 510(k) clearance to the latest Olympus endoscopes that feature new extended depth of field technology.

Savara Gets Refusal-to-File Letter for Molbreevi BLA

[ Price : $8.95]

FDA issues Savara a Refusal-to-File (RTF) letter for its BLA for Molbreevi (molgramostim) inhalation solution for treating autoimm...

Interchangeability for Celltrions Humira Biosimilar Expanded

[ Price : $8.95]

FDA grants an expanded interchangeable designation for Celltrions Yuflyma (adalimumab-aaty), a biosimilar copy of AbbVies Humira. ...

BD Recalls Esophagogastric Balloon Tamponade Tubes

[ Price : $8.95]

BD recalls its Esophagogastric Balloon Tamponade Tubes to update the devices instructions for use due to difficulties in removing ...

FDA Approves Liquidias Pulmonary Hypertension Drug

[ Price : $8.95]

FDA approves Liquidias Yutrepia (Treprostinil), a new inhalation powder designed to treat adults with pulmonary arterial hypertens...

Susvimo Approved for Diabetic Retinopathy

[ Price : $8.95]

FDA approves Roches Susvimo (ranibizumab injection) 100 mg/mL for treating diabetic retinopathy.

FDA Backs Covid JN.1-Lineage for Next Boosters

[ Price : $8.95]

FDA advises Covid-19 vaccine makers to formulate their products to match the currently circulating JN.1-lineage and preferentially...